Company news

Aethlon Medical, Inc. news in 2025

Aethlon Medical, Inc.'s news releases, calls and decks from 2025, newest first.

View company

Aethlon Medical Announces Pricing of a Private Placement and Warrant Inducement, Priced At-The-Market for Aggregate Gross Proceeds of $3.3 Million

December 5, 2025

Aethlon Medical Announces Publication of Preclinical Data Showing That the GNA Affinity Resin in the Hemopurifier® Binds to Extracellular Vesicles in Long COVID patient samples and Decreases Inflammatory microRNAs

December 2, 2025

Aethlon Medical Announces Fiscal Q2 2025 Financial Results and Corporate Update

November 12, 2025

Aethlon Medical to Release Fiscal Second Quarter Financial Results and Host Conference Call on November 12, 2025

November 7, 2025

Aethlon Medical's Hemopurifier® shows Changes in Extracellular Vesicles, Extracellular MicroRNAs, and T Cell Numbers in Australian Oncology Clinical Trial

October 7, 2025

Aethlon Medical Announces Pricing of $4.5 Million Public Offering

September 4, 2025

Aethlon Medical Announces Issuance of Hemopurifier® Patents for the Treatment of Long COVID and COVID-19-associated Coagulopathy (CAC)

September 3, 2025

Aethlon Medical Announces Financial Results for the Fiscal First Quarter Ended June 30, 2025, and Provides Corporate Update

August 13, 2025

Aethlon Medical to Release Fiscal First Quarter Financial Results and Host Conference Call on August 13, 2025

August 5, 2025

Aethlon Medical, Inc. Announces Positive Data Safety Monitoring Board Review and Recommendation to Advance to Next Clinical Trial Cohort

July 15, 2025

Aethlon Medical Announces Financial Results for the Fiscal Fourth Quarter Ended March 31, 2025, and Provides Corporate Update

June 26, 2025

Aethlon Medical to Release Fiscal Fourth Quarter Financial Results and Host Conference Call on June 26, 2025

June 20, 2025

Aethlon Medical Treats Second Patient in Australian Hemopurifier(R) Cancer Trial

June 19, 2025

Aethlon Medical Treats Second Patient in Australian Hemopurifier® Cancer Trial

June 18, 2025

Presenting on Emerging Growth Conference 83 Day 1 on June 17; Register to live stream

June 16, 2025

Aethlon Medical to Present New Pre-Clinical Data at the Keystone Symposium on Long COVID and Other Post-Acute Infection Syndromes

June 9, 2025

Aethlon Medical Announces Publication of Preclinical Data Showing Ability of the Hemopurifier® to Remove Platelet-Derived Extracellular Vesicles from Plasma

May 14, 2025

Aethlon Medical Publishes Preclinical Data on the Hemopurifier® in Transplant Immunology Journal

March 10, 2025

Aethlon Medical to Present at the Emerging Growth Conference on February 19, 2025

February 12, 2025

Aethlon Medical Announces Financial Results for the Fiscal Third Quarter Ended December 31, 2024 and Provides Corporate Update

February 11, 2025

Aethlon Medical to Release Fiscal Third Quarter Financial Results and Host Conference Call on February 12, 2025

February 4, 2025

Aethlon Medical Treats First Patient in Australian Hemopurifier® Cancer Trial

January 28, 2025

Calls in 2025

Decks in 2025